☰

Michael Hallett - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Philosophy
Tree Info Similar researchers PubMed Report error

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gruosso T, Gigoux M, Bertos N, Manem V, Zuo D, Saleg S, Souleimanova M, Zhao H, Johnson R, Monette A, Ramos VM, Hallett M, Stagg J, Lapointe R, Omeroglu A, et al. Abstract PD6-05: Distinct tumor microenvironments stratify triple negative breast cancer into immune subtypes Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-05  0.348
2017 Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M. Interactions between the tumor and the blood systemic response of breast cancer patients. Plos Computational Biology. 13: e1005680. PMID 28957325 DOI: 10.1371/Journal.Pcbi.1005680  0.32
2017 Liu H, Dowdle JA, Khurshid S, Sullivan NJ, Bertos N, Rambani K, Mair M, Daniel P, Wheeler E, Tang X, Toth K, Lause M, Harrigan ME, Eiring K, Sullivan C, ... ... Hallett M, et al. Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. Developmental Cell. 41: 392-407.e6. PMID 28535374 DOI: 10.1016/J.Devcel.2017.04.024  0.372
2016 Lesurf R, Aure MR, Mørk HH, Vitelli V, Lundgren S, Børresen-Dale AL, Kristensen V, Wärnberg F, Hallett M, Sørlie T. Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. Cell Reports. PMID 27396337 DOI: 10.1016/J.Celrep.2016.06.051  0.344
2016 Turpin J, Ling C, Crosby EJ, Hartman ZC, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, Ozcelik J, Hallett M, Mills GB, Cardiff RD, Gray JW, Griffith OL, Muller WJ. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene. PMID 27157621 DOI: 10.1038/Onc.2016.129  0.403
2016 Cyr-Depauw C, Northey JJ, Tabariès S, Annis MG, Dong Z, Cory S, Hallett M, Rennhack JP, Andrechek ER, Siegel PM. Chordin-like 1 suppresses BMP4-induced breast cancer cell migration and invasion. Molecular and Cellular Biology. PMID 26976638 DOI: 10.1128/Mcb.00600-15  0.367
2016 Boulay PL, Mitchell L, Turpin J, Huot-Marchand JÉ, Lavoie C, Sanguin-Gendreau V, Jones L, Mitra S, Livingstone JM, Campbell S, Hallett M, Mills GB, Park M, Chodosh L, Strathdee D, et al. Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression. Cancer Research. PMID 26933086 DOI: 10.1158/0008-5472.Can-15-2782  0.41
2016 Saleh S, Gruosso T, Gigoux M, Bertos N, Omeroglu A, Zuo D, Meterissian S, Hallett M, Park M. Abstract IA23: Deconvolution of the triple-negative breast cancer microenvironment Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Ia23  0.394
2016 Gruosso T, Gigoux M, Bertos N, Saleh S, Omeroglu A, Zuo D, Zhao H, Souleimanova M, Weaver V, Meterissian S, Hallett M, Park M. Abstract A15: Mechanisms of CD8+ T cell immunosuppression in triple negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A15  0.347
2015 Hosein AN, Livingstone J, Buchanan M, Reid JF, Hallett M, Basik M. A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer. Bmc Cancer. 15: 130. PMID 25884794 DOI: 10.1186/S12885-015-1117-0  0.376
2015 Gigoux M, Gruosso T, Bertos N, Saleh S, Omeroglu A, Zhao H, Souleimanova M, Meterissian S, Hallett M, Park M. Abstract A69: The immunological environment in triple negative breast cancer; impact on clinical outcomes towards a prognostic clinical test Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A69  0.371
2015 Saleh SM, Savage P, Laferrière J, Cory S, Bertos N, Souleimanova M, Zhao H, Zacksenhaus E, Muller W, Hallett M, Park M. Abstract A79: Mouse models of breast cancer identify oncogene-associated stroma subtypes Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A79  0.395
2015 Gruosso T, Verteuil DAd, Saleh S, Lesurf R, Zhao H, Davis R, Zuo D, Cardiff R, Gregg J, Hallett M, Park M. Abstract LB-200: Loss of the scaffold protein Kibra in a mouse model of triple-negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-200  0.403
2014 Tofigh A, Suderman M, Paquet ER, Livingstone J, Bertos N, Saleh SM, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y, Omeroglu A, Ursini-Siegel J, ... ... Hallett M, et al. The prognostic ease and difficulty of invasive breast carcinoma. Cell Reports. 9: 129-42. PMID 25284793 DOI: 10.1016/J.Celrep.2014.08.073  0.329
2014 Vadnais C, Shooshtarizadeh P, Rajadurai CV, Lesurf R, Hulea L, Davoudi S, Cadieux C, Hallett M, Park M, Nepveu A. Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers. Biology Open. 3: 937-46. PMID 25217618 DOI: 10.1242/Bio.20148193  0.386
2014 Cheishvili D, Chik F, Li CC, Bhattacharya B, Suderman M, Arakelian A, Hallett M, Rabbani SA, Szyf M. Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness. Carcinogenesis. 35: 2436-46. PMID 25178277 DOI: 10.1093/Carcin/Bgu181  0.407
2014 Hudson J, Ha JR, Sabourin V, Ahn R, La Selva R, Livingstone J, Podmore L, Knight J, Forrest L, Beauchemin N, Hallett M, Park M, Ursini-Siegel J. p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition. Molecular and Cellular Biology. 34: 3689-701. PMID 25071152 DOI: 10.1128/Mcb.00341-14  0.388
2014 Stefanska B, Cheishvili D, Suderman M, Arakelian A, Huang J, Hallett M, Han ZG, Al-Mahtab M, Akbar SM, Khan WA, Raqib R, Tanvir I, Khan HA, Rabbani SA, Szyf M. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3118-32. PMID 24763612 DOI: 10.1158/1078-0432.Ccr-13-0283  0.325
2014 Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, ... ... Hallett M, et al. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer. Science Signaling. 7: ra38. PMID 24757178 DOI: 10.1126/Scisignal.2004839  0.316
2013 Wallace JA, Li F, Balakrishnan S, Cantemir-Stone CZ, Pecot T, Martin C, Kladney RD, Sharma SM, Trimboli AJ, Fernandez SA, Yu L, Rosol TJ, Stromberg PC, Lesurf R, Hallett M, et al. Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. Plos One. 8: e71533. PMID 23977064 DOI: 10.1371/Journal.Pone.0071533  0.367
2013 Stefanska B, Suderman M, Machnes Z, Bhattacharyya B, Hallett M, Szyf M. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis. 34: 2738-49. PMID 23955541 DOI: 10.1093/Carcin/Bgt273  0.32
2013 Stefanska B, Bouzelmat A, Huang J, Suderman M, Hallett M, Han ZG, Al-Mahtab M, Akbar SM, Khan WA, Raqib R, Szyf M. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes. Plos One. 8: e68439. PMID 23950870 DOI: 10.1371/Journal.Pone.0068439  0.325
2013 Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M, Combe C, Loriot S, Cubel G, Dugot-Senant N, Vital A, Loiseau H, Gosline SJ, Taouji S, ... Hallett M, et al. Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα. Cancer Research. 73: 4732-43. PMID 23752693 DOI: 10.1158/0008-5472.Can-12-3989  0.314
2013 Schade B, Lesurf R, Sanguin-Gendreau V, Bui T, Deblois G, O'Toole SA, Millar EK, Zardawi SJ, Lopez-Knowles E, Sutherland RL, Giguère V, Kahn M, Hallett M, Muller WJ. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. Cancer Research. 73: 4474-87. PMID 23720052 DOI: 10.1158/0008-5472.Can-12-3925  0.38
2013 Knight JF, Lesurf R, Saleh SM, Davis RR, Zhao H, Zuo D, Cardiff RD, Gregg J, Hallett M, Park M. Abstract PR01: Loss of the hippo pathway scaffold “Kibra” in a mouse model of human claudin-low breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-Pr01  0.405
2013 Cyr-Depauw C, Northey J, Dong Z, Cory S, Hallett M, Siegel PM. Abstract A084: TGFβ induces Chordin-like 1 (Chrdl1) expression in ErbB2 expressing breast cancer cells with attenuated ShcA signaling Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A084  0.405
2013 Lai AZ, Thompson C, Cory S, Zhao H, Chughtai N, Hallett M, Park M. Abstract 967: Establishing mechanisms of acquired resistance to Met inhibitor in Met-addicted gastric cancer cell lines. Cancer Research. 73: 967-967. DOI: 10.1158/1538-7445.Am2013-967  0.311
2013 Lai A, Cory S, Zhao H, Sehat B, Tofigh A, Guiot M, Thompson C, Bell ES, Bertos N, Ferri LE, Hallett M, Park M. Abstract B69: Dynamic reprogramming of signaling following Met inhibition reveals pathways for cell proliferation and negative feedback in gastric cancer. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B69  0.333
2012 Mourskaia AA, Amir E, Dong Z, Tiedemann K, Cory S, Omeroglu A, Bertos N, Ouellet V, Clemons M, Scheffer GL, Park M, Hallett M, Komarova SV, Siegel PM. ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone. Breast Cancer Research : Bcr. 14: R149. PMID 23174366 DOI: 10.1186/Bcr3361  0.357
2012 Stefanska B, Suderman M, Huang J, Hallett M, Han Z, Szyf M. Abstract 4028: Therapeutic relevance of two novel cancer candidate genes,RASAL2andNENF, activated by DNA hypomethylation Cancer Research. 72: 4028-4028. DOI: 10.1158/1538-7445.Am2012-4028  0.371
2012 Lai AZ, Cory S, Zhao H, Bell ES, Hallett M, Park M. Abstract B45: Met-Dependent Positive and Negative Signaling Cascades in Gastric Cancer Cells Clinical Cancer Research. 18: B45-B45. DOI: 10.1158/1078-0432.Mechres-B45  0.335
2012 Bertos N, Finak G, Lesurf R, Saleh S, Zhao H, Souleimanova M, Meterrisian S, Omeroglu A, Hallett M, Park M. Abstract ES8-2: Breast Cancer Stroma: A Predictor of Clinical Outcome and Tumour Heterogeneity Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Es8-2  0.399
2011 Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, Szyf M. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Research. 71: 5891-903. PMID 21747116 DOI: 10.1158/0008-5472.Can-10-3823  0.403
2011 Sansregret L, Vadnais C, Livingstone J, Kwiatkowski N, Awan A, Cadieux C, Leduy L, Hallett MT, Nepveu A. Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure. Proceedings of the National Academy of Sciences of the United States of America. 108: 1949-54. PMID 21245318 DOI: 10.1073/Pnas.1008403108  0.302
2011 Tabariès S, Dong Z, Annis MG, Omeroglu A, Pepin F, Ouellet V, Russo C, Hassanain M, Metrakos P, Diaz Z, Basik M, Bertos N, Park M, Guettier C, Adam R, ... Hallett M, et al. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene. 30: 1318-28. PMID 21076473 DOI: 10.1038/Onc.2010.518  0.365
2011 Stefanska B, Bhattacharyya B, Suderman M, Huang J, Hallett M, Han Z, Szyf M. Abstract 96: The functional role of DNA hypomethylation in liver cancer Cancer Research. 71: 96-96. DOI: 10.1158/1538-7445.Am2011-96  0.366
2011 Hanson ES, Fathers KE, Rajadurai CV, Monast A, Cory S, Zhao H, Zuo D, Grosset A, Gaboury L, Madore J, Hallett M, Siegel P, Park M. Abstract 918: A key role for Crk adaptor proteins in basal breast cancer tumor growth in vivo Cancer Research. 71: 918-918. DOI: 10.1158/1538-7445.Am2011-918  0.399
2010 Ursini-Siegel J, Cory S, Zuo D, Hardy WR, Rexhepaj E, Lam S, Schade B, Jirstrom K, Bjur E, Piccirillo CA, Denardo D, Coussens LM, Brennan DJ, Gallagher WM, Park M, ... ... Hallett M, et al. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. Cancer Research. 70: 7776-87. PMID 20924104 DOI: 10.1158/0008-5472.Can-10-2229  0.389
2010 Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. Plos One. 5: e12093. PMID 20711474 DOI: 10.1371/Journal.Pone.0012093  0.393
2010 Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Molecular Oncology. 4: 357-68. PMID 20663721 DOI: 10.1016/J.Molonc.2010.06.007  0.362
2010 Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2147-56. PMID 20215530 DOI: 10.1158/1078-0432.Ccr-09-1611  0.384
2010 Fathers KE, Rodrigues S, Zuo D, Murthy IV, Hallett M, Cardiff R, Park M. CrkII transgene induces atypical mammary gland development and tumorigenesis. The American Journal of Pathology. 176: 446-60. PMID 20008144 DOI: 10.2353/Ajpath.2010.090383  0.388
2010 Stefanska B, Bhattacharyya B, Han ZG, Huang J, Suderman M, Hallett M, Rabbani SA, Szyf M. Abstract 158: The landscape of DNA hypomethylation in liver cancer, its correlation with other cancers, and its potential role in cancer Cancer Research. 70: 158-158. DOI: 10.1158/1538-7445.Am10-158  0.365
2010 Rose A, Annis M, Dong Z, Pepin F, Hallett M, Park M, Siegel P. Abstract P1-02-02: Processing of GPNMB by ADAM-10 in Breast Tumors Releases an Extracellular Domain with Angiogenic Properties Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P1-02-02  0.395
2009 Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, ... ... Hallett M, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature. 461: 1084-91. PMID 19847259 DOI: 10.1038/Nature08486  0.331
2009 Ranger JJ, Levy DE, Shahalizadeh S, Hallett M, Muller WJ. Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Research. 69: 6823-30. PMID 19690134 DOI: 10.1158/0008-5472.Can-09-1684  0.384
2009 Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Research. 69: 6149-57. PMID 19622763 DOI: 10.1158/0008-5472.Can-09-1251  0.396
2009 Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 12903-8. PMID 19617568 DOI: 10.1073/Pnas.0810402106  0.396
2009 Finak G, Laferrière J, Hallett M, Park M. [The tumor microenvironment: a new tool to predict breast cancer outcome]. Mã©Decine Sciences : M/S. 25: 439-41. PMID 19480818 DOI: 10.1051/Medsci/2009255439  0.35
2009 Schade B, Rao T, Dourdin N, Lesurf R, Hallett M, Cardiff RD, Muller WJ. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis. The Journal of Biological Chemistry. 284: 19018-26. PMID 19435886 DOI: 10.1074/Jbc.M109.018937  0.378
2009 Finak G, Bertos N, Hallett M, Park M. Stromal signature identifies basal breast cancers Nature Medicine. 15: 238. DOI: 10.1038/Nm0309-238A  0.352
2008 Brown SE, Suderman MJ, Hallett M, Szyf M. DNA demethylation induced by the methyl-CpG-binding domain protein MBD3. Gene. 420: 99-106. PMID 18602768 DOI: 10.1016/J.Gene.2008.05.009  0.315
2008 Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine. 14: 518-27. PMID 18438415 DOI: 10.1038/Nm1764  0.36
2007 Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM. Osteoactivin promotes breast cancer metastasis to bone. Molecular Cancer Research : McR. 5: 1001-14. PMID 17951401 DOI: 10.1158/1541-7786.Mcr-07-0119  0.376
2007 Schade B, Lam SH, Cernea D, Sanguin-Gendreau V, Cardiff RD, Jung BL, Hallett M, Muller WJ. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles. Cancer Research. 67: 7579-88. PMID 17699761 DOI: 10.1158/0008-5472.Can-06-4724  0.375
2006 Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Research : Bcr. 8: R58. PMID 17054791 DOI: 10.1186/Bcr1608  0.378
Show low-probability matches.